- About Us
- Our Research
- Diseases and conditions
- Research Groups
- Research support and facilities
- Aboriginal and Torres Strait Islander Health
- Participate in our research
- Research history
- Glossary of research terms
- Support Us
- Why support QIMR Berghofer?
- Ways to help
- Book a tour or guest speaker
- Our supporters
- Thanks to our donors
- News & Events
- Contact Us
- Our Services
- CMV study
- Queensland Pancreatic Cancer Study
- QIMR Berghofer Centre for Immunotherapy and Vaccine Development
QIMR Berghofer Medical Research Institute is under the control and management of the QIMR Berghofer Council. The Governor-in-Council appoints all members of the Council.
Current QIMR Berghofer Councillors
The Hon. Paul de Jersey
The Honourable Paul de Jersey AC BA LLB (Hons)
Justice Paul de Jersey is Chair of the QIMR Berghofer Council since 2013.
Justice de Jersey was called to the Bar in 1971 and appointed to Her Majesty’s Counsel in 1981. A Judge of the Supreme Court of Queensland, Justice de Jersey was appointed Chief Justice of Queensland in 1998.
A strong supporter of local not-for-profit organisations, Justice de Jersey acts as patron for a number of organisations including the Medico-Legal Society of Queensland, the Queensland Justices Association Inc and the UQ Pro Bono Law Centre and has lead the board of the Australian Cancer Society and the Queensland Cancer Fund.
Centenary Medal (2003)
Hon LLD (Qld) (2000), Hon Doctor of the University (USQ) (2008)
Life Member Bar Association of QueenslandAt the Bar, a broad general practice with a focus on the commercial field; appeared in constitutional cases before the High Court of Australia; appeared before the Judicial Committee of the Privy Council.
Appointed a Judge of the Supreme Court of Queensland in 1985; Commercial Causes Judge 1986-1989; Chairman, Supreme Court Library Committee 1988- 1994; Chairman, Attorney-General’s Consultative Committee on Computerised Legal Information Retrieval 1990-1991; Judge constituting the Mental Health Tribunal, 1994-1996; President, Queensland Industrial Court, 1996-1997; Chairman, Law Reform Commission (Qld) 1996-1997.
Chair, Judicial Section, Law Association of Asia and the Pacific (LAWASIA), since 2006.
Visitor, The University of the South Pacific, 2006-2009.
Chancellor of the Anglican Diocese of Brisbane since 1991; member of the Chapter of St John’s Cathedral since 1989; member of the Council of the Anglican Church Grammar School 1990-1997.
President, Australian Cancer Society 1998-2001 (Vice President 1995-1998); Trustee of the National Breast Cancer Foundation 1994-1999; Chairman of the Queensland Cancer Fund 1994-2001.
Member, Centenary of Federation Committee (Queensland), 1998-2002.
Chair, Queensland Constitutional Convention, Gladstone, June 1999.
Honorary Consultant Member, Independent Commission on the Future of Policing (UK), from 2012.
Patronage as follows:
Art from the Margins
BBC Indigenous Fund
Camerata of St John’s
Christian Lawyers Society
CLEAR Australia International Ltd
Corporate Lawyers Association (Qld)
Gold Coast District Law Association Inc (GCDLA)
Indigenous barristers’ fund of the Bar Association of Queensland, The Mullenjaiwakka Trust
King’s College Foundation
Medico-Legal Society of Qld
Queensland Justices Association Inc
Queensland Public Interest Law Clearing House (QPILCH)
United Service Club
UQ Pro Bono Law Centre
Royal Commonwealth Society (Qld)
Mr Christopher Coyne
Mr Christopher Coyne
Mr Coyne is Deputy Chair of QIMR Berghofer Council, a solicitor of the Supreme Court of Queensland, an accredited specialist in the field of Commercial Litigation, specialising in insurance law, health law, corporate governance and risk management. Following his admission as a solicitor in 1979 he practised law in Brisbane and was a partner in the national law firm Clayton Utz from 1984 to 2004.
Mr Coyne now practices on his own account. He was appointed an Adjunct Professor of The University of Queensland School of Law in 2002. Chris is Board Chairman of Lexon Insurance Pte Ltd (Queensland Law Society, Singapore Captive Insurer), a Director of the Incorporated Council of Law Reporting for the State of Queensland, past president Medico-Legal Society of Queensland and Australian Insurance Law Association and former legal member Australian Health Ethics Committee. Christopher is sessional member of the Queensland Civil and Administrative Tribunal and also a member of the QIMR Berghofer Personnel Administration Committee.
Professor Bryan Campbell
AM MD BS FRACP FRACMA
Professor Campbell was formerly Chief Health Officer of Queensland and Head of The University of Queensland Medical School.
He has been a Councillor of the Royal Australasian College of Physicians, the Royal Australian College of Medical Administrators and a member of the National Health and Medical Research Council (NHMRC). He was Deputy Chair of the Australian Health Ethics Committee and a member of the NHMRC Embryo Research Licensing Committee until June 2006.
Professor Campbell is the Chair of the QIMR Berghofer Finance and Audit Committee.
Distinguished Professor Judith Clements
BAppSc MAppSc PhD
Distinguished Professor Clements has over 20 years’ experience as a basic researcher in biomedical research, primarily in the general field of molecular endocrinology.Her current research seeks understanding of the molecular basis of hormone dependent cancers such as prostate and ovarian cancer.
She is currently Scientific Director of the Australian Prostate Cancer Research Centre-Queensland and Program Leader of the Cancer Program within the Institute of Health and Biomedical Innovation at the Queensland University of Technology. She coordinates the Australian Prostate Cancer BioResource, a national tissue bank for prostate cancer research. She is also an NHMRC Principal Research Fellow and an NHMRC Academy member since 2009. In 2007 Professor Clements was awarded the prestigious international Frey-Werle Foundation Gold Medal for her significant contributions to the kallikrein protease field.
Professor Clements is Chair of the QIMR Berghofer Appointment and Promotions Committee.
Associate Professor Paula Marlton
MB BS (Hons I) FRACP FRCPA
Paula Marlton is the Head of Leukaemia and Lymphoma Services at the Princess Alexandra Hospital where she is also Deputy Director of Haematology. Her previous appointments include three years at the MD Anderson Cancer Centre in Houston, Texas. She has extensive experience in clinical research including the role of principal investigator for national multi-centre trials and supervisor of molecular translational research associated with trials. She was the founding Chair of the Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Committee and has established and continues to direct the ALLG Tissue Bank. Her other professional roles include Medical Advisor and Board member of the Leukaemia Foundation, member of several Drug Advisory Boards and Government and College Advisory Committees as well as a wide range of academic and clinical service roles.
Dr Jeannette Young
Dr Jeannette Young
MB BS FRACMA AFACHSE
Dr Jeannette Young is the Chief Health Officer for Queensland, a role she has filled since August 2005. Prior to this, she held the position of Executive Director of Medical Services at the Princess Alexandra Hospital in Brisbane and has previously worked in a range of positions in Queensland and Sydney. She has specialist qualifications as a Fellow of the Royal Australasian College of Medical Administrators and as a Fellow by Distinction of the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom. She is an Adjunct Professor at Queensland University of Technology and at Griffith University.
Today she is responsible for such matters as health disaster planning and response, aero-medical retrieval services, licensing of private pospitals, organ and tissue donation services, provision of health services to prisoners, cancer screening services, communicable diseases, environmental health and other population health services and mental health, alcohol and other drugs policy and legislation.
Along with sitting on the QIMR Berghofer Council, Dr Young is a member of numerous State and National committees and Boards, some of which include the Queensland Board of the Medical Board of Australia, NHMRC, the Australian Health Protection Committee, the Clinical Technical Ethical Principal Committee of Australian Health Ministers’ Advisory Council, the Australian Population Health Development Principal Committee and the newly created Australian National Preventive Health Agency Advisory Council.
Professor Alan Pettigrew
BSc (Hons) PhD FAICD
In January 2001, Professor Pettigrew was appointed by the Commonwealth Minister for Health and Aging as the inaugural Chief Executive Officer of the National Health and Medical Research Council. He served in that role until the end of 2005 when he was appointed as the Vice-Chancellor and Chief Executive Officer of the University of New England. Professor Pettigrew retired from the University in 2009. He also served as a member of the Board of the Australian Universities Quality Agency until 2010.
Professor Pettigrew is currently an Adjunct Professor in the College of Medicine, Biology and Environment at the Australian National University and an Honorary Professorial Fellow at the University of Melbourne. He is a member of the Advisory Board of the L.H. Martin Institute for Higher Education Leadership and Management, and the Advisory Council of Research Australia Philanthropy. Professor Pettigrew is a member of the Cooperative Research Centres Committee of the Australian Government and has been appointed as an adviser to the Chief Scientist of Australia. He is also a consultant to universities on higher education leadership, management and research.
Mr Rodney Wylie
OBE BComm BA FCA FAICD
Rod Wylie is a Brisbane-based chartered accountant with substantial experience in investment, company management and corporate governance issues across a wide range of organisations, in many cases with nationwide and international activities.
He has been involved through Board or Council membership in the administration of a number of professional and community not-for-profit groups.
Mr Wylie chairs the QIMR Investment Committee and is a member of the QIMR Finance and Audit Committee and QIMR Personnel Administration Committee.
Mr Ian Fraser
Mr Ian Fraser is a chartered accountant with more than 45 years experience, a non-executive company director and business advisor.
Mr Fraser was an audit and corporate advisory partner of KPMG for 27 years before retiring in 2004. He has extensive experience in audit, particularly public company audit, accounting, project leadership and management, due diligence and litigation support. He was the Honorary Treasurer of the Australian Institute of Company Directors (Queensland) from 1999 to 2008.
Professor Nicholas Fisk
MBBS PhD MBA FRANZCOG FRCOG DDU CMFM
Professor Fisk was appointed Executive Dean of Health Sciences at The University of Queensland in 2010. He practices as a maternal-fetal medicine specialist and high risk obstetrician at the Royal Brisbane and Women's Hospital, and maintains a research group in The University of Queensland Centre for Clinical Research (UQCCR).
Between 1992-2007 he was Professor of Obstetrics and Fetal Medicine at Imperial College and Queen Charlotte's Hospital, London, where his laboratory and clinical research program achieved an international reputation in fetal diagnosis and treatment. His main research interests have been in human fetal mesenchymal stem cell biology and monochorionic multiple pregnancy, but also spanned non-invasive prenatal diagnosis, fetal nociception, caesarean section, preterm labour, obstetric ultrasound and drug development in obstetrics. A fetal-medicine subspecialist with an MBA and a PhD in fetal physiology, he has authored nearly 400 publications, and is a past President of the International Fetal Medicine and Surgery Society. He reviews for numerous international grant bodies, and is a member of several editorial boards including PLoS Medicine.
He is passionate about driving clinical research in a bench to bedside environment, to link wet and dry laboratories with patients, and to foster the training of tomorrow's translational researchers.